Healius Limited (HLS.AX)

1,1950 -0,0550 (-4,40%) Börsenschluss: 04:10PM AEST

Healius Limited

Liberty Place
Level 22 161 Castlereagh Street
Sydney, NSW 2000
Australia
61 2 9432 9400
https://www.healius.com.au

Sektor(en): Healthcare
Branche: Diagnostics & Research
Vollzeitmitarbeiter: 10.500

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Paul D. Anderson	MD, Group CFO, CEO & Director	220,62k	N/A	N/A
Mr. John McKechnie	Advisor	898,22k	855,47k	N/A
Dr. Jan Van Rooyen	Head & Group Executive of Healius Pathology	20,68k	N/A	N/A
Dr. Phil Lucas	Chief Executive of Lumus Imaging	N/A	N/A	N/A
Ian Mcphan	Chief Operating Officer of Healius Pathology	N/A	N/A	N/A
Sharon Ng	Head of Group FP&A	N/A	N/A	N/A
Ms. Mary Ellen Weaver AGIA	Company Secretary	N/A	N/A	N/A
Dr. John Houston	Advisor	1,07M	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in AUD.

Beschreibung

Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs; Lumus Imaging; and Montserrat brands. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.

Corporate Governance

Healius Limiteds ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.